These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 11025664)

  • 1. The function of PML in p53-dependent apoptosis.
    Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
    Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
    Salomoni P; Bernardi R; Bergmann S; Changou A; Tuttle S; Pandolfi PP
    Blood; 2005 May; 105(9):3686-90. PubMed ID: 15626733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytoplasmic PML mutant inhibits p53 function.
    Bellodi C; Kindle K; Bernassola F; Cossarizza A; Dinsdale D; Melino G; Heery D; Salomoni P
    Cell Cycle; 2006 Nov; 5(22):2688-92. PubMed ID: 17172828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML is a direct p53 target that modulates p53 effector functions.
    de Stanchina E; Querido E; Narita M; Davuluri RV; Pandolfi PP; Ferbeyre G; Lowe SW
    Mol Cell; 2004 Feb; 13(4):523-35. PubMed ID: 14992722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S; Kuo C; Bisi JE; Kim MK
    Nat Cell Biol; 2002 Nov; 4(11):865-70. PubMed ID: 12402044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic PML function in TGF-beta signalling.
    Lin HK; Bergmann S; Pandolfi PP
    Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML.
    Chan JY; Li L; Fan YH; Mu ZM; Zhang WW; Chang KS
    Biochem Biophys Res Commun; 1997 Nov; 240(3):640-6. PubMed ID: 9398618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for PML and the nuclear body in genomic stability.
    Zhong S; Hu P; Ye TZ; Stan R; Ellis NA; Pandolfi PP
    Oncogene; 1999 Dec; 18(56):7941-7. PubMed ID: 10637504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
    Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP
    J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
    Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
    Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML is essential for multiple apoptotic pathways.
    Wang ZG; Ruggero D; Ronchetti S; Zhong S; Gaboli M; Rivi R; Pandolfi PP
    Nat Genet; 1998 Nov; 20(3):266-72. PubMed ID: 9806545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
    Komura N; Asakawa M; Umezawa K; Segawa K
    Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V; Tini M; Egan DA; Evans RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.